Clinical Trials · NCT02685397
Management of Castration-Resistant Prostate Cancer with Oligometastases
- Phase
- Phase 2/Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Sir Mortimer B. Davis - Jewish General Hospital
- Enrollment
- 102
- Start date
- Oct 2016
- Locations
- 11 sites, Canada
- Primary endpoint
- Radiographic Progression-free Survival